arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

ENvue Medical, Inc.

FEED
$0.40 ▲ +0.02 (+3.95%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
50 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
11
Health
Poor
Bearish
auto_awesome

Analytical Summary

ENvue Medical, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.3M
Dividend Yield
Revenue Growth -36.3%
Op. Margin None
ROIC -11.7%
FCF / Share $-1.32
Trailing P/E
Price / Book 0.1x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

50-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$653.00K
↓ -36.3%
Net Income Profit after all expenses
$-3.82M
↓ -53.2%
Operating Margin Operating profit as % of sales
-311.2%
↓ -72.2%
FCF / Share Free cash flow per share
$-1.32
↑ +38.9%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
0
Returns
16
Financial Health
5
Cash Quality
41

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 13 years · 50 quarters